InvestSMART

Imugene Limited (ASX: IMU) - Announcements

- Current share price for IMU : $0.082

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$40 Strategic Alliance Update 11 Jan 2010 9:00AM $0.076 $0.082 risen by 7.89%
$40 Quarterly Report and Appendix 4C 28 Oct 2009 7:10PM $0.100 $0.082 fallen by 18%
$40 Appendix 4E and 2009 Financial Report 28 Aug 2009 8:23AM $0.099 $0.082 fallen by 17.17%
$40 Response to ASX Query 19 Aug 2009 2:05PM $0.120 $0.082 fallen by 31.67%
$40 Appendix 4C - quarterly 31 Jul 2009 1:54PM $0.085 $0.082 fallen by 3.53%
$40 Swine Influenza Update 27 Jul 2009 3:32PM $0.090 $0.082 fallen by 8.89%
$40 Appendix 4C - quarterly 30 Apr 2009 1:34PM n/a $0.082 n/a
$40 Swine Influenza Vaccines 28 Apr 2009 1:36PM $0.125 $0.082 fallen by 34.40%
$40 Half Yearly Report and Accounts 26 Feb 2009 11:41AM $0.075 $0.082 risen by 9.33%
$40 Quarterly Report and Apprndix 4C 30 Jan 2009 4:12PM $0.074 $0.082 risen by 10.81%
$40 Imugene and Merial establish a Strategic Alliance 31 Dec 2008 9:35AM $0.085 $0.082 fallen by 3.53%
$40 Trading Halt - Amended 30 Dec 2008 10:29AM n/a $0.082 n/a
$40 Trading Halt 30 Dec 2008 10:13AM n/a $0.082 n/a
$40 Appendix 4C - quarterly 31 Oct 2008 11:29AM $0.045 $0.082 risen by 82.22%
$40 PRRS Final Trial Results 10 Oct 2008 2:00PM $0.049 $0.082 risen by 67.35%
$40 Preliminary Final Report 29 Aug 2008 5:52PM $0.062 $0.082 risen by 32.26%
$40 PRRS Vaccine Trial Success 20 Aug 2008 2:41PM $0.068 $0.082 risen by 20.59%
$40 Quarterly activity and cashflow reports 31 Jul 2008 5:53PM n/a $0.082 n/a
$40 Imugene`s PRRS vaccine for pigs enters further trials 4 Jul 2008 12:27PM n/a $0.082 n/a
$40 Cocci Vaccine Trial Success 15 May 2008 10:22AM $0.100 $0.082 fallen by 18%
$40 Quarterly Activities Update and Appendix 4C 30 Apr 2008 4:55PM $0.070 $0.082 risen by 17.14%
$40 Cocci Vaccine Trial in Progress 7 Apr 2008 2:18PM n/a $0.082 n/a
$40 Half Yearly Report and Accounts 29 Feb 2008 8:25AM n/a $0.082 n/a
$40 Quarterly Activities Update and Appendix 4C 31 Jan 2008 3:31PM $0.115 $0.082 fallen by 28.70%
$40 Non-renounceable Rights Issue 3 Dec 2007 9:49AM $0.145 $0.082 fallen by 43.45%

1101 - 1125 of 1186 results

Page 45 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.